Laboratory Corp of America Holdings (LH)

140.10
1.70 1.20
NYSE : Health Care
Prev Close 141.80
Open 142.10
Day Low/High 139.85 / 142.28
52 Wk Low/High 119.51 / 146.63
Volume 571.76K
Avg Volume 697.30K
Exchange NYSE
Shares Outstanding 102.30M
Market Cap 14.51B
EPS 7.10
P/E Ratio 19.48
Div & Yield N.A. (N.A)

Latest News

LabCorp Completes Acquisition Of Pathology Associates Medical Laboratories

LabCorp® (NYSE:LH) has completed the acquisition of Pathology Associates Medical Laboratories (PAML) from former owners Providence Health & Services (Providence) and Catholic Health Initiatives (CHI).

LabCorp To Webcast Its Annual Meeting Of Shareholders

LabCorp® (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, 2017 at 9:00 a.

LabCorp Enhances VistaSeq Hereditary Cancer Test Portfolio With Addition Of New Panels And New Genes That Can Be Assessed

LabCorp® (NYSE: LH) today announced a significant enhancement to its proprietary VistaSeq SM Hereditary Cancer portfolio, with ten new test panels focusing on the risk of specific hereditary cancer syndromes.

LabCorp's Acquisition Of Pathology Associates Medical Laboratories Clears Antitrust Review

LabCorp® (NYSE: LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to LabCorp's acquisition of Pathology Associates Medical Laboratories,...

LabCorp Completes Acquisition Of Assets Of Mount Sinai Health System Clinical Outreach Laboratories

LabCorp ® (NYSE: LH), a leading global life sciences company, has completed the previously announced acquisition of assets of the Mount Sinai Health System Clinical Outreach Laboratories.

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.

LabCorp To Exclusively Offer The M3 Checklist, A Multi-Condition Mental Health Screening Tool

LabCorp ® (NYSE:LH) and M-3 Information, LLC today announced the nationwide availability through LabCorp of the peer-reviewed, clinically validated M3 Checklist assessment for mental illness.

Laboratory Corporation Of America® Holdings Announces 2017 First Quarter Results And Updates 2017 Guidance

Laboratory Corporation of America ® Holdings (LabCorp ® or the "Company") (NYSE: LH) today announced results for the first quarter ended March 31, 2017, and updated 2017 guidance.

Covance To Expand Large-Molecule Development Capabilities In The UK

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business will expand its biopharmaceutical...

Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

LabCorp Commends Reps. Dr. Bucshon, DeGette For Releasing Bipartisan Discussion Draft Of the Diagnostic Accuracy And Innovation Act (DAIA)

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), a leading global life sciences company, today issued the following statement regarding a discussion draft of the Diagnostic Accuracy and Innovation...

Gary Huff (Photo: Business Wire)

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), a leading global life sciences company, today announced that Gary Huff is being promoted to CEO of LabCorp Diagnostics, one of the company's two...

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Interest

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) announced today that for the period of March 12, 2017 to September 11, 2017, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon...

LabCorp Is Scheduled To Present At The 2017 Barclays Global Healthcare Conference

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced it will participate at the 2017 Barclays Global Healthcare Conference.

LabCorp Is Scheduled To Present At The 38th Annual Raymond James Institutional Investors Conference

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced it will participate at the 38 th Annual Raymond James Institutional Investors Conference.

LabCorp To Acquire Pathology Associates Medical Laboratories From Providence Health & Services And Catholic Health Initiatives

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE:LH), Providence Health & Services (Providence) and Catholic Health Initiatives (CHI), today announced that they have entered into a...

Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'

Amid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy'

LabCorp's earnings call took place on the heels of a media report earlier this month that the company was in discussions to buy Pharmaceutical Product Development.

Laboratory Corporation Of America® Holdings Announces Record 2016 Fourth Quarter And Full Year Results And Provides 2017 Guidance

Laboratory Corporation of America ® Holdings (LabCorp ® or the "Company") (NYSE:LH) today announced results for the fourth quarter and year ended December 31, 2016, and provided 2017 guidance.

LabCorp To Acquire Assets Of Mount Sinai Health System Clinical Outreach Laboratories

LabCorp To Acquire Assets Of Mount Sinai Health System Clinical Outreach Laboratories

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH), a world leading life sciences company, and the Mount Sinai Health System (Mount Sinai), one of the largest health systems in metropolitan New...

LabCorp Is Scheduled To Present At The 35th Annual J.P. Morgan Healthcare Conference

LabCorp Is Scheduled To Present At The 35th Annual J.P. Morgan Healthcare Conference

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced it will participate at the 35 th Annual J.

Leading Genetic Testing Companies Join Forces To Launch The Coalition For Access To Prenatal Screening

Leading Genetic Testing Companies Join Forces To Launch The Coalition For Access To Prenatal Screening

Coalition aims to make noninvasive prenatal testing easily accessible to all pregnant women

Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

INC Research Holdings Seen as Likely LabCorp. Takeover Target

INC Research Holdings Seen as Likely LabCorp. Takeover Target

The contract research organization has been viewed as a logical takeout target of LabCorp. for some time now.

Computerworld Names Covance's Dimitris Agrafiotis A Premier 100 Technology Leader

Computerworld Names Covance's Dimitris Agrafiotis A Premier 100 Technology Leader

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH), the world's leading healthcare diagnostics company, is proud to announce that IDG's Computerworld recently recognized Dimitris Agrafiotis,...

LabCorp Is Scheduled To Present At The 2016 Credit Suisse Healthcare Conference

LabCorp Is Scheduled To Present At The 2016 Credit Suisse Healthcare Conference

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced it will participate at the 2016 Credit Suisse Healthcare Conference.

Laboratory Corporation Of America® Holdings Announces 2016 Third Quarter Results And Updates 2016 Guidance

Laboratory Corporation Of America® Holdings Announces 2016 Third Quarter Results And Updates 2016 Guidance

Laboratory Corporation of America ® Holdings (LabCorp ®) (NYSE: LH) today announced results for the quarter ended September 30, 2016.

Covance Central Laboratory Services Ranks No. 1 In Global Investigator Satisfaction For The Third Consecutive Time

Covance Central Laboratory Services Ranks No. 1 In Global Investigator Satisfaction For The Third Consecutive Time

An independent report has established that physician clinical-trial investigators identify Covance Central Laboratory Services as their "most preferred" central laboratory more than three times as often as the nearest...